Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.

Genefluence's rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelsea Test identifies UTI-causing bacteria and antibiotic resistance genes at the point ...

GalactomannanLab InterpretationAspergillus A positive galactomannan result supports possible invasive aspergillosis but does ...

Britain’s latest Covid 'hotspot' has been flagged in north London after figures showed 58.3% of PCR tests in Islington coming ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

Friendly A positive stool result does not automatically require medication. The treatment decision depends on dehydration, ...

A UKHSA-led evaluation of 61 nasopharyngeal swabs found that bait-enriched whole genome sequencing recovered an average of 85 ...

Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...

The UK Covid-19 Inquiry has found Scotland acted earlier than the rest of the UK to isolate hospital discharges into care homes, but still entered the pandemic unprepared, with 4,272 residents dying ...

Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026 .bwalignc { text-align: center; list-style-position: inside } .bwblockalignl { margin-left: 0px; margin-right: ...

GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as the first and only immunotherapy for adults with stage II and III ...